CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 46 enrolled
Drug / intervention
Endobarrier Linerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00985491
NCT00985491Phase 2Completed
CompareCT.gov

A Pilot Trial of the GI EndoBarrier Liner for Short Term Weight Loss in Subjects Who Are Candidates for Bariatric Surgery

Morphic Medical Inc.·interventional·Posted Sep 28, 2009·Updated Sep 15, 2016

In Brief

A Phase 2 clinical trial evaluating Endobarrier Liner for Obesity. Completed, enrolled 46 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether the GI Endobarrier Liner is safe and effective.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesChile
Collaborators--

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 28, 2009
Enrollment StartOct 1, 2008
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6.8 yearsPosted 16.8 years ago

Interventions

Endobarrier Linerdevice

Medical device placed endoscopically in the duodenum